DNLI - Denali Therapeutics misses by $0.02 beats on revenue May, 08 2019 05:04 PM Denali Therapeutics Inc. Denali Therapeutics (NASDAQ:DNLI): Q1 GAAP EPS of -$0.41 misses by $0.02.Revenue of $4.2M (+556.3% Y/Y) beats by $1.22M.Press ReleaseMore news on: Denali Therapeutics Inc., Earnings news and commentary, Healthcare stocks news,